Research Study: Survival, remission, and quality of life in diabetic cats
Rothlin-Zachrisson N, Öhlund M, Röcklinsberg H, Ström Holst B. Survival, remission, and quality of life in diabetic cats. J Vet
EveryCat Health Foundation advances feline health by supporting groundbreaking research and education. The research articles and summaries detailed here cannot be used for specific advice on your cat’s medical conditions. If you have questions about your cat’s health, remember that your own veterinary healthcare team is always the appropriate source for immediate medical needs and information.
Rothlin-Zachrisson N, Öhlund M, Röcklinsberg H, Ström Holst B. Survival, remission, and quality of life in diabetic cats. J Vet
Cook S, Wittenburg L, Yan VC, Theil JH, Castillo D, Reagan KL, Williams S, Pham CD, Li C, Muller FL,
Coggins SJ, Norris JM, Malik R, Govendir M, Hall EJ, Kimble B, Thompson MF. Outcomes of treatment of cats with
Yiew XT, Bateman SW, Hahn RG, Bersenas AME; Evaluation of the Distribution and Elimination of Balanced Isotonic Crystalloid, 5% Hypertonic
Dezubiria P, Amirian ES, Spera K, Crawford PC, Levy JK. Animal shelter management of feline leukemia virus and feline immunodeficiency
Healey EA, Andre NM, Miller AD, Whittaker GR, Berliner EA. Outbreak of feline infectious peritonitis (FIP) in shelter-housed cats: molecular
Marieke Knies, M; Teske, E; and Kooistra, H. Evaluation of the FreeStyle Libre, a flash glucose monitoring system, in client-owned
MT20-007 Synergistic inhibitory effects of clopidogrel and rivaroxaban on platelet function and platelet-dependent thrombin generation in cats (An EveryCat-funded research
Barnacle, J., Chow, Y., Borman, A., et.al (2023). The first three reported cases of Sporothrix brasiliensis cat-transmitted sporotrichosis outside South
W21-048 D-Dimer isolation and analysis of immunoreactivity in dogs, cats, and horses. (An EveryCat-funded grant project interim report) Principal
MacQuiddy, B.; Moreno, J.; Frank, J.; Mcgrath, S.; (2022). “Survey of risk factors and frequency of clinical signs observed with
Gruen, M. E., Myers, J., & Lascelles, B. (2021). Efficacy and Safety of an Anti-nerve Growth Factor Antibody (Frunevetmab) for
MTW17-020, W19-026, W20-003 -Cook, S.E., Vogel, H., Castillo, D., Olsen, M., Pedersen, N., Murphy, B.G. (2022). Investigation of monotherapy and
Moretto, L., Lavaud, A., Suter, A., Günther, C., Pot, S., & Glaus, T. (2021). Reliability of detecting fundus abnormalities associated
MT17-002: Investigating appropriate dosing for gabapentin sedation in cats with and without chronic kidney disease. (An EveryCat-funded grant project, final